Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Resverlogix Corp. T.RVX

Alternate Symbol(s):  T.RVX.W.A | RVXCF

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.


Recent & Breaking News (TSX:RVX)

Resverlogix Announces a Corporate Update Conference Call & Webcast

Canada NewsWire August 29, 2013

Resverlogix Announces a Corporate Update Conference Call & Webcast

PR Newswire August 29, 2013

Resverlogix Closes $1.6 million Private Placement

Canada NewsWire August 14, 2013

Resverlogix Announces $1.6 million Private Placement

Canada NewsWire August 12, 2013

InvestorsGuru.com 19 Filtered Mid-Day Market Movers Recap

Investors Guru July 6, 2013

Resverlogix Corporation is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Newsfile July 5, 2013

AQM Copper soars 129% on investment news: Canadian market movers

Elizabeth Walters July 2, 2013

Resverlogix to host Conference Call & Webcast with Q&A

Canada NewsWire June 28, 2013

Resverlogix to host Conference Call & Webcast with Q&A

PR Newswire June 28, 2013

IIROC Trade Resumption - RVX

Canada NewsWire June 27, 2013

IIROC Trade Resumption - Resverlogix Corp.

Newsfile June 27, 2013

Resverlogix Reports Top-Line Results from ASSURE Clinical Trial

Canada NewsWire June 27, 2013

Resverlogix Reports Top-Line Results from ASSURE Clinical Trial

PR Newswire June 27, 2013

IIROC Trading Halt - RVX

Canada NewsWire June 27, 2013

Zenith Epigenetics Corp. commences operations

Canada NewsWire June 3, 2013

Zenith Epigenetics Corp. commences operations

PR Newswire June 3, 2013

Resverlogix Corp. announces completion of spin-out transaction

Canada NewsWire June 3, 2013

Resverlogix Corp. announces completion of spin-out transaction

PR Newswire June 3, 2013

Resverlogix Corp. shareholders approve plan of arrangement

Canada NewsWire May 28, 2013

Resverlogix Corp. shareholders approve plan of arrangement

PR Newswire May 28, 2013